# clm_6053DA9FFA3A

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 379,091,000 United States dollar  
valid_from: 2019-06-30  
valid_to: 2019-09-30  
published: 2019-08-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_E4FC8BA4267A  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly research and development: 379,091,000 United States dollar", as of 2019-06-30 (until 2019-09-30). Claim clm_6053DA9FFA3A, https://asof.is/claim/clm_6053DA9FFA3A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532019000037/0000875320-19-000037-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-08-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532019000037/0000875320-19-000037-index.htm (primary, SEC EDGAR 10-Q Q2 FY2019, published 2019-08-01)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_research_and_development | 339,490,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_6053DA9FFA3A](/claim/clm_6053DA9FFA3A.md) | [clm_1A5BF9CE8A15](/claim/clm_1A5BF9CE8A15.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.